This inventor holds 17 USPTO granted patents, primarily in Immunology Research. Top assignees: Cemu Bioteknik Ab, Pierre Fabre Medicament, Dynal as. Active years: 1992-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Uppsala, SE (1992 - 1998)
- Upsala, SE (1992 - 1998)
- Kvarnbogatan, SE (1999)
- 05 Stockholm, SE (2000)
- Stockholm, SE (2000 - 2003)
- Masvager, SE (2003)
Company Filing History:
3 out of 3 
3 out of 269 
2 out of 8 Years Active: 1992-2003
Areas of Expertise:
Title: Mathias Uhlen: Innovator in Immunology and Biotechnology
Introduction
Mathias Uhlen is a prominent inventor based in Uppsala, Sweden. He has made significant contributions to the fields of immunology and biotechnology, holding a total of 17 patents. His work focuses on developing innovative solutions for medical challenges, particularly in the area of respiratory syncytial virus (RSV) and insulin production.
Latest Patents
Among his latest patents is a groundbreaking invention related to complexes of immunogens derived from RSV surface glycoprotein G. This patent describes a complex where the immunogen is covalently coupled to a support molecule, specifically a polypeptide fragment that binds to mammalian serum albumin. This invention has potential applications in treating RSV infections and developing vaccines. Another notable patent involves the recombinant expression of insulin C-peptide. This method outlines a process for producing insulin C-peptide by expressing a multimeric polypeptide in a host cell and subsequently cleaving it to release single copies of the peptide.
Career Highlights
Mathias Uhlen has worked with several notable companies throughout his career, including Cemu Bioteknik AB and Pierre Fabre Medicament. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in the biotechnology sector.
Collaborations
Throughout his career, Uhlen has collaborated with esteemed colleagues, including Bjorn Nilsson and Stefan Stahl. These partnerships have fostered a collaborative environment that has led to the development of impactful inventions.
Conclusion
Mathias Uhlen's contributions to immunology and biotechnology are noteworthy, with a focus on innovative solutions for medical challenges. His patents and collaborations reflect his commitment to advancing scientific knowledge and improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile